Li Wei, Zhang Zijia, Berik Entezar, Liu Yawen, Pei Wenqiang, Chen Sihan, Wu Wenyong, Wang Zhaojun, Kong Xinqin, Long Huali, Lei Min, Wang Jennifer Yiyang, Li Zhaoxia, Liu Liangfeng, Hou Jinjun, Wu Wanying, Guo De-An
National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; Beijing Key Lab of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Phytomedicine. 2024 Mar;125:155269. doi: 10.1016/j.phymed.2023.155269. Epub 2023 Dec 9.
Energy deficiency is the characteristic of chemotherapy-induced cachexia (CIC) which is manifested by muscle wasting. glycolysis, tricarboxylic acid (TCA) cycle, and lipid metabolism are central to muscle bioenergy production, which is vulnerable to chemotherapy during cancer treatment. Recent investigations have spotlighted the potential of Shenqi Fuzheng injection (SQ), a Chinese proprietary medicine comprising Radix Codonopsis and Radix Astragali, in alleviating CIC. However, the specific effects of SQ on muscle energy metabolism remains less explored.
Here, we integrated transcriptomics, spatial metabolomics, gas chromatography-mass spectrometry targeted quantitative analysis, and transmission electron microscopy techniques, combined with Seahorse live-cell metabolic analysis to reveal the changes in genes and pathways related to energy metabolism in the CIC model and SQ's protective effects at molecular and functional levels.
Our data showed that chemotherapeutic agents caused glycolysis imbalance, which further leads to metabolic derangements of TCA cycle intermediates. SQ maintained glycolysis balance by facilitating pyruvate fluxing to mitochondria for more efficient bioenergy production, which involved a dual effect on promoting functions of mitochondrial pyruvate dehydrogenase complexes and inhibiting lactate dehydrogenase for lactate production. As a result of the sustained pyruvate level achieved by SQ administration, glycolysis balance was maintained, which further led to the preservation of mitochondrial integrity and function of electron transport chain, thereby, ensuring the normal operation of the TCA cycle and the proper synthesis of adenosine triphosphate (ATP). The above results were further validated using the Seahorse live-cell assay.
In conclusion, our study highlights SQ as a promising strategy for CIC management, emphasizing its ability to harmonize the homeostasis of the muscle bioenergetic profile. Beyond its therapeutic implications, this study also offers a novel perspective for the development of innovative treatments in the realm of herbal medicine.
能量缺乏是化疗诱导的恶病质(CIC)的特征,表现为肌肉萎缩。糖酵解、三羧酸(TCA)循环和脂质代谢是肌肉生物能量产生的核心,在癌症治疗期间易受化疗影响。最近的研究突出了参芪扶正注射液(SQ)的潜力,这是一种由党参和黄芪组成的中成药,可缓解CIC。然而,SQ对肌肉能量代谢的具体作用仍有待进一步探索。
在这里,我们整合了转录组学、空间代谢组学、气相色谱 - 质谱靶向定量分析和透射电子显微镜技术,并结合海马活细胞代谢分析,以揭示CIC模型中与能量代谢相关的基因和途径的变化,以及SQ在分子和功能水平上的保护作用。
我们的数据表明,化疗药物导致糖酵解失衡,进而导致TCA循环中间体的代谢紊乱。SQ通过促进丙酮酸流入线粒体以实现更高效的生物能量产生来维持糖酵解平衡,这涉及对促进线粒体丙酮酸脱氢酶复合物功能和抑制乳酸脱氢酶产生乳酸的双重作用。由于给予SQ后丙酮酸水平持续维持,糖酵解平衡得以维持,进而导致线粒体完整性和电子传递链功能得以保留,从而确保TCA循环的正常运行和三磷酸腺苷(ATP)的正常合成。上述结果通过海马活细胞测定进一步得到验证。
总之,我们的研究强调了SQ作为CIC管理的一种有前景的策略,强调其协调肌肉生物能量谱稳态的能力。除了其治疗意义外,本研究还为草药领域创新治疗方法的开发提供了新的视角。